November 12th, 2026
Home | Log in!
❤ ❤ ❤ ❤ ❤
Welcome to FreshFiction

Are you a reader
or an author?

Help us personalize your experience. Choose your role below.
You can always change this later using the switcher button.

or

You can switch anytime using the floating button.

Limited Time Fresh Fiction Access

Exclusive Marketing Opportunities for Authors

Curious about how Fresh Access helps authors gain more visibility and connect with active readers?

Discover premium promotional opportunities, enhanced exposure, and author-focused services designed to help your books stand out.

Read More →
On Top Shelf
Fresh Pick
RIDER OF DRAGONS
📚 New Books This Week 📰 Latest News 🎪 Reader Games

THE GOLDILOCKS GENOME
By: Elizabeth Reed Aden

Spark Press
May 2024
On Sale: May 21, 2024
ISBN: 1684632544
EAN: 9781684632541
Kindle: B0CJBQX6WR
Paperback / e-Book
Add to Wish List

Other Editions
Paperback (May 2024)

Thriller Medical

When San Francisco–based FDA epidemiologist Dr. Carrie Hediger uncovers a rash of unexplained deaths while investigating the suspiciously convenient death of her best friend, she becomes determined to find answers—even if it leads her to a murderer, and even if confronting authority, using her wiles, and bending the rules to get justice risks her future in the FDA.

To unravel the puzzle, Carrie assembles a team: some talented post-doctoral fellows, a quirky pharmacologist, an unctuous chemist, and a skeptical FBI agent that she can’t help her attraction for. Together, they follow the data through the twists and turns, eventually uncovering that the Goldilocks effect in prescription drugs—the premise that people are inclined to seek “just the right amount” of something—is central to understanding these mysterious deaths. Through the twists and turns, Carrie and her team enter a race to uncover the truth . . . and catch a killer.

Grounded in real data analysis techniques, real science and pharmacology, and actual current psychiatric practices, The Goldilocks Genome is simultaneously a taut, race-against-time thriller and a condemnation of the psychiatric industry’s failure to implement genetic-based “personalized medicine”—a problem that persists to this day.